BJ-003

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBJ-003
Drug Alias NameBJ-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBoji Biomedical Technology (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoji Biomedical Technology (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A